Atlanta 1/18/2013 4:00:14 AM
Guided Therapeutics, Inc. (Stock Symbol: OTCBB: GTHP) is now on LinkMyStock.com
Guided Therapeutics, Inc. has joined LinkMyStock.com. Now Stock Brokers, Brokerage Firms and Investors/Shareholders from around the world who follow Guided Therapeutics, Inc. can link directly to Guided Therapeutics, Inc. Link My Stock Hub. Brokers and Brokerage Firms that link to Guided Therapeutics, Inc. typically are familiar with the company and can facilitate transactions in Guided Therapeutics, Inc. security. Investors linking to Guided Therapeutics, Inc. usually are either existing shareholders looking to stay informed when Guided Therapeutics, Inc. posts new information or people that are simply interested in Guided Therapeutics, Inc. that are not yet or may never become shareholders.
LinkMyStock is a premier financial networking platform designed specifically for public companies, brokerage firms, brokers and investors. LinkMyStock.com provides a network that consists of brokers, brokerage firms and investors that can link directly to the companies that they follow. With brokers from around the world having the ability to select companies to link to that are members of Link My Stock this provides investors with the ability to locate brokers and contact them to find out more information about a company they are interested in learning more about.
LinkMyStock.com provides every member with their own hub where they post content. Content sections include; press releases, blogs, pictures, videos, Right Now status updates, events, jobs and more in order to attract more visitors and increase the number of search results along with improving indexing.
To link to the Guided Therapeutics, Inc.'s Link My Stock Hub sign into your Link My Stock Hub or Join Link My Stock today.
About Guided Therapeutics, Inc.
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) is developing a rapid and painless testing platform for the early detection of disease based on its patented biophotonic technology that utilizes light to detect disease at the cellular level. The company’s first planned product is the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial, with women at risk for cervical disease, the technology was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. Guided Therapeutics has also entered into a partnership with Konica Minolta to develop a non-invasive test for Barrett’s Esophagus using the technology platform.
